Chronic hepatitis C with extrahepatic manifestations.

Area of Science:

• Hepatology
• Dermatology
• Immunology

Background:

• Chronic hepatitis C (HCV) is a significant global health concern, frequently asymptomatic and incidentally diagnosed.
• HCV infection exhibits diverse clinical courses and is often identified through its extrahepatic manifestations.
• Extrahepatic conditions associated with HCV include thyroiditis, porphyria cutanea tarda, cryoglobulinemia, glomerulonephritis, sicca syndrome, thrombocytopenia, lichen planus, diabetes mellitus, and B-cell lymphoproliferative disorders.

Observation:

• A young male patient presented with a confirmed diagnosis of hepatitis C and porphyria cutanea tarda.
• The patient initiated systemic interferon therapy for his conditions.
• Following the commencement of interferon treatment, the patient developed psoriasis.

Findings:

• This case illustrates a potential association between interferon therapy for hepatitis C and the subsequent development of psoriasis in a patient with pre-existing porphyria cutanea tarda.
• The interplay between viral infection, autoimmune phenomena, and therapeutic interventions warrants further investigation.

Implications:

• This case underscores the complex relationship between hepatitis C, its extrahepatic manifestations, and treatment-induced dermatological conditions.
• Clinicians should be vigilant for the emergence of new dermatological conditions, such as psoriasis, in patients undergoing interferon therapy for chronic hepatitis C, particularly those with other autoimmune or inflammatory conditions.
• Further research is needed to elucidate the mechanisms underlying this association and to inform clinical management strategies.